TABLE 2.
Correlation of analyte levels in oral fluids with levels in serum during immune activation in HIV-seropositive persons
| Sample and parameter | Correlation coefficient (P value), no. of observations
|
|||
|---|---|---|---|---|
| NPT in serum | β2M in serum | sTNFαRII in serum | CD4+ counts | |
| OMT | ||||
| NPT | 0.2996 (0.0676), 38 | 0.4365 (0.0061), 38 | 0.5509 (0.0016), 30 | −0.1857 (0.2643), 38 |
| β2M | 0.5327 (0.0006), 38 | 0.6474 (0.0001), 38 | 0.6190 (0.0003), 30 | −0.3046 (0.0630), 38 |
| sTNFαRII | 0.2597 (0.1154), 38 | 0.5924 (0.0001), 38 | 0.4072 (0.0255), 30 | −0.2607 (0.1139), 38 |
| CD4+ count | −0.4103 (0.0117), 37 | −0.5393 (0.0006), 37 | −0.5194 (0.0039), 29 | |
| Saliva | ||||
| NPT | 0.0570 (0.8222), 18 | 0.1382 (0.5845), 18 | 0.3400 (0.1675), 18 | −0.2703 (0.2781), 18 |
| β2M | 0.1142 (0.6518), 18 | 0.3195 (0.1963), 18 | 0.4438 (0.0651), 18 | −0.2940 (0.2363), 18 |
| sTNFαRII | 0.0016 (0.9949), 18 | 0.4961 (0.0363), 18 | 0.3578 (0.1449), 18 | −0.1995 (0.4274), 18 |
| CD4+ count | −0.5206 (0.0268), 18 | −0.6360 (0.0046), 18 | −0.5236 (0.0258), 18 | |